Complement
AI-powered virtual teaching assistant
- B2B
- SaaS
- AI-native
About Complement
AI-powered virtual professor interacts orally via 3D avatar, delivering personalized lessons, answering questions, and evaluating students in real-time.
Key facts
- Industry
- Software Development
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2024
- Revenue
- $1.6M – $8.4MTamtam estimate
- Website
- complement.education
Complement in the news
- FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
FDA granted Fast Track status to Complement Therapeutics' gene therapy CTx001 for treating geographic atrophy in AMD, enabling accelerated clinical development.
- FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy
FDA cleared IND for Complement Therapeutics' gene therapy CTx001 to start clinical trials for geographic atrophy in AMD patients.
- Major GAIN for Complement Therapeutics with FDA IND clearance
Complement Therapeutics secured FDA IND clearance for its gene therapy CTx001 to treat Geographic Atrophy in AMD, enabling a Phase I/II trial starting in 2026.
- Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform
Complement 1 secured $16M seed funding to expand its AI-powered, clinically validated lifestyle coaching platform that improves cancer patient outcomes and reduces healthcare costs.
Complement at a glance
Complement is a B2B SaaS company in the Software Development industry, headquartered in Paris, Île-de-France, France.
Complement was founded in 2024.
Complement has 1–10 employees.
Complement's revenue is $1.6M – $8.4M (Tamtam estimate).
Selling to companies like Complement?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies